Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.

Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.

BACKGROUND: An acquired V617F mutation in JAK2 occurs in most patients with polycythaemia vera, but is seen in only half those with essential thrombocythaemia and idiopathic myelofibrosis. We aimed to assess whether patients with the mutation are biologically distinct from those without, and why th...

Полное описание

Библиографические подробности
Главные авторы:	Campbell, P, Scott, L, Buck, G, Wheatley, K, East, C, Marsden, J, Duffy, A, Boyd, E, Bench, A, Scott, M, Vassiliou, G, Milligan, D, Smith, SR, Erber, W, Bareford, D, Wilkins, B, Reilly, J, Harrison, C, Green, A
Формат:	Journal article
Язык:	English
Опубликовано:	2005

Схожие документы

JAK2 V617F mutation identifies a biologically distinct subtype of essential thrombocythemia which resembles polycythemia vera.
по: Green, A, и др.
Опубликовано: (2005)

Skin cancer in essential thrombocythaemia and polycythaemia vera patients treated with hydroxycarbamide
по: Abhinav Mathur, и др.
Опубликовано: (2022-11-01)

Cerebral venous sinus thrombosis in JAK2 V617F positive polycythaemia vera presenting as a haemorrhagic stroke
по: N. T. Weerasinghe, и др.
Опубликовано: (2021-12-01)

Real world experience with ropeginterferon alpha-2b (Besremi) in essential thrombocythaemia and polycythaemia vera following exposure to pegylated interferon alfa-2a (Pegasys)
по: Jumoke Okikiolu, и др.
Опубликовано: (2023-01-01)

Polycythaemia vera and central sleep apnoea.
по: Stradling, JR, и др.
Опубликовано: (1980)

Recurrent Episodes of Angioedema as Presenting Feature of JAK2-Positive Myeloproliferative Disorder Consistent with Polycythaemia Vera
по: Laith Al-Azrai, и др.
Опубликовано: (2021-07-01)

Profile of polycythaemia vera in South Western Nigeria
по: Patrick Olanrewaju Osho, и др.
Опубликовано: (2022-01-01)

Evaluation of erythrocytapheresis compared to phlebotomy in polycythaemia vera patients
по: Sergio Cabibbo, и др.
Опубликовано: (2024-10-01)

Improvement in polycythaemia vera after parathyroidectomy for primary hyperparathyroidism
по: Pavai Sthaneshwar, и др.
Опубликовано: (2023-10-01)

Splenic Infarctions in Polycythaemia Vera are Not Always a Catastrophe
по: ELMustafa Abdalla, и др.
Опубликовано: (2022-06-01)

The janus kinase 2 (JAK2) mutation: A review of its role in polycythaemia vera and other myeloproliferative disorders
по: M U Nwagu
Опубликовано: (2011-01-01)

A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis
по: McMullin, M, и др.
Опубликовано: (2018)

Study of JAK2V617F gene allele burden in polycythemia vera
по: F. Khalilova, и др.
Опубликовано: (2020-10-01)

Longitudinal trends of peripheral blood counts in polycythaemia vera and essential thrombocythemia patients in the UK
по: Lewis Carpenter, и др.
Опубликовано: (2022-08-01)

Advances in management of primary myelofibrosis and polycythaemia vera: Implications in clinical practice
по: Shanti Amé, и др.
Опубликовано: (2023-08-01)

MTAP-related increased erythroblast proliferation as a mechanism of polycythaemia vera
по: Chartsiam Tipgomut, и др.
Опубликовано: (2021-11-01)

A guideline for the diagnosis and management of polycythaemia vera. A British Society for haematology guideline
по: McMullin, M, и др.
Опубликовано: (2018)

A man with concomitant polycythaemia vera and chronic myeloid leukemia: the dynamics of the two disorders
по: Bee, P.C., и др.
Опубликовано: (2010)

Sigmoid Venous Thrombosis in JAK2 V617F Mutated Polycythemia Vera
по: Cilomar Martins De Oliveira Filho, и др.
Опубликовано: (2022-01-01)

Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera
по: Susanne Schnittger, и др.
Опубликовано: (2009-03-01)

MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort.
по: Beer, P, и др.
Опубликовано: (2008)

PB2192: JAK2 V617F ALLELE BURDEN AND THROMBOTIC EVENTS IN PATIENTS WITH JAK2 V617F POSITIVE POLYCYTHEMIA VERA OR ESSENTIAL THROMBOCYTHEMIA AT HIGH RISK OF THROMBOSIS
по: Yun Hui Hwang, и др.
Опубликовано: (2023-08-01)

Extent of hematopoietic involvement by TET2 mutations in JAK2V617F polycythemia vera
по: Sabina I. Swierczek, и др.
Опубликовано: (2011-05-01)

Cerebral venous sinus thrombosis in polycythemia vera patients with JAK2V617F mutation
по: Hui-Xin Shen, и др.
Опубликовано: (2021-05-01)

Polyglobulia Masquerading as Polycythaemia Vera Presenting as Superior Mesenteric Vein Thrombosis: A Case Report
по: Janhavi Nitin Mahajan, и др.
Опубликовано: (2022-10-01)

Development and validation of a sequential two-step algorithm for the screening of individuals with potential polycythaemia vera
по: Miguel Piris-Villaespesa, и др.
Опубликовано: (2021-01-01)

PB2178: EVALUATION OF JAK2 EXON 12 MUTATIONS IN PATIENTS WITH JAK2 (V617F)-NEGATIVE POLYCYTHEMIA VERA
по: Sahar Khosravi, и др.
Опубликовано: (2023-08-01)

Clinical significance of MPL mutations in essential thrombocythemia: Analysis of the PT-1 cohort.
по: Beer, P, и др.
Опубликовано: (2007)

Impact of platelet glycoprotein polymorphisms upon clinical events in essential thrombocythaemia patients enrolled in the PT1 trial
по: Robinson, SE, и др.
Опубликовано: (2007)

Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes.
по: Wilkins, B, и др.
Опубликовано: (2008)

Distinguishing essential thrombocythemia JAK2V617F from polycythemia vera: limitations of erythrocyte values
по: Richard T. Silver, и др.
Опубликовано: (2019-11-01)

JAK2 p.V617F Variants in Non-Blood DNA from Patients with Polycythemia Vera
по: Naoki Mori, и др.
Опубликовано: (2023-08-01)

Absence of JAK2 V617F-mutated polycythemia vera in obstructive sleep apnea-associated erythrocytosis
по: Stephen E. Langabeer
Опубликовано: (2022-12-01)

JAK2 V617F prevalence in Brazilian patients with polycythemia vera, idiopathic myelofibrosis and essential thrombocythemia
по: Bárbara da Costa Reis Monte-Mór, и др.
Опубликовано: (2007-03-01)

Association of polycythemia vera with positive JAK2V617F mutation and myasthenia gravis: A report of two cases
по: Sreethish Sasi, и др.
Опубликовано: (2021-01-01)

Modification of British committee for standards in haematology diagnostic criteria for essential thrombocythaemia
по: Harrison, C, и др.
Опубликовано: (2014)

Modification of British Committee for Standards in Haematology diagnostic criteria for essential thrombocythaemia.
по: Harrison, C, и др.
Опубликовано: (2014)

Polycythemia vera: Correlation of JAK2V617F mutation with clinicohematologic characteristics. A single centre experience.
по: Deepti Mutreja, и др.
Опубликовано: (2014-08-01)

Decrease in JAK2V617F allele burden is not a prerequisite to clinical response in patients with polycythemia vera
по: Emil Kuriakose, и др.
Опубликовано: (2012-04-01)

Enhanced calreticulin expression in red cells of polycythemia vera patients harboring the JAK2V617F mutation
по: Mégane Brusson, и др.
Опубликовано: (2017-07-01)